Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 500 shares at $608.68 ($304K) on 2022-02-23, disclosed to the SEC on 2022-02-24.
Open-market sale of $304k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |